Advanced Proteome Therapeutics Corporation APTCF

RE:Told you so, didn't I

[Goldnboy1]

The company just reposted their investor deck.

In it is a planned event calendar. 

Im told there was a delay in development to ensure a conjugation patent had the best protection.  That's now complete. 

Due to this the company can now file for new linker IP. The planned events calendar is showing the completion of a linker project in May it appears. 

Typically when this company has invented ip in the past they have ran pretty hard. So for investors looking for short term 2x-5x returns. This is likely a very good place to find them short term. 

The current CEO is Dr. Ben Krantz. He hasn't failed at anything yet. He is doing his thing for the first time ever. So your statement is false.